Seckin, Tamer Ahmet – Trademark Portfolio

Entity Type: 01

Seckin, Tamer Ahmet holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 6 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include SECKIN, DR. SECKIN, SECKIN ENDOMETRIOSIS CENTER, THE DOCTOR WILL SEE YOU NOW, and THE DOCTOR WILL SEE YOU NOW: RECOGNIZING AND TREATING ENDOMETRIOSIS. The owner is based in New York, NY.

872 5th Avenue

New York, NY 10021

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Seckin, Tamer Ahmet's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (6 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Seckin, Tamer Ahmet have?

Seckin, Tamer Ahmet has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned.

What trademark classes does Seckin, Tamer Ahmet file in?

Seckin, Tamer Ahmet files trademarks across 1 Nice Classification class. The most active classes are Class 44 (Medical Services). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Seckin, Tamer Ahmet's most well-known trademarks?

Seckin, Tamer Ahmet's registered trademark portfolio includes well-known marks such as SECKIN, DR. SECKIN, SECKIN ENDOMETRIOSIS CENTER, THE DOCTOR WILL SEE YOU NOW, and THE DOCTOR WILL SEE YOU NOW: RECOGNIZING AND TREATING ENDOMETRIOSIS. These are among 5 currently registered trademarks in the portfolio.

What is Seckin, Tamer Ahmet's trademark registration success rate?

Seckin, Tamer Ahmet has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.